The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill

OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have additive insulinotropic effects when coadministered in health. We aimed to determine whether GIP confers additional glucose lowering to that of GLP-1 in the critically ill. RESEARCH DESIGN AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Michael Y., Fraser, Jonathan D., Chapman, Marianne J., Sundararajan, Krishnaswamy, Umapathysivam, Mahesh M., Summers, Matthew J., Zaknic, Antony V., Rayner, Christopher K., Meier, Juris J., Horowitz, Michael, Deane, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781541/
https://www.ncbi.nlm.nih.gov/pubmed/23835687
http://dx.doi.org/10.2337/dc13-0307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781541/
https://www.ncbi.nlm.nih.gov/pubmed/23835687
http://dx.doi.org/10.2337/dc13-0307

Ejemplares similares